Xun Meng

6PUBLICATIONS
44CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 17, 2026
ADCE-T02 - a Next Generation Antibody Drug Conjugate Targeting Tissue Factor Demonstrates Superior Preclinical Efficacy and Tolerability.

|Sep 17, 2025
SPARC: A Multipayload ADC Architecture for Programmable Drug Combinations.

Wenlong Sun, Weining Weng, Jing Shi

|Sep 05, 2023
A Cell Surface-Binding Antibody Atlas Nominates a MUC18-Directed Antibody-Drug Conjugate for Targeting Melanoma.

Jing Shi, Tao Jiao, Qian Guo

|Jun 23, 2023
MTX-13, a Novel PTK7-Directed Antibody-Drug Conjugate with Widened Therapeutic Index Shows Sustained Tumor Regressions for a Broader Spectrum of PTK7-Positive Tumors.

Chao Kong, Junyi Pu, Qianqian Zhao

|Jun 11, 2023
AMT-562, a Novel HER3-targeting Antibody-Drug Conjugate, Demonstrates a Potential to Broaden Therapeutic Opportunities for HER3-expressing Tumors.

Weining Weng, Tao Meng, Junyi Pu

|Jan 24, 2023
Antibody-Exatecan Conjugates with a Novel Self-immolative Moiety Overcome Resistance in Colon and Lung Cancer.

Weining Weng, Tao Meng, Qianqian Zhao

Pageof 1

Frequent Collaborators

5 joint publications

Weining Weng

5 joint publications

Wenhao Hu

4 joint publications

Tao Meng

4 joint publications

Jianjian Zhang